Large scale platform for motion detection and fluorescence imaging in zebrafish...
Large scale platform for motion detection and fluorescence imaging in zebrafish models of neurological disorders
The PhenoTECH project aims to develop a novel technology with high-throughput capacity for screening and phenotyping of genetic models of disease. PhenoTECH will enable an unprecedented capability to monitor and control multiple p...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
EIN2020-112381
MODELIZACION DE ENFERMEDADES NEURODEGENERATIVAS
15K€
Cerrado
EQC2018-005332-P
Detección precoz de enfermedades neurodegenerativas con inmu...
67K€
Cerrado
SAF2011-22506
ANALISIS DE TRANSCRIPTOMAS EN MODELOS DE ENFERMEDADES NEUROD...
133K€
Cerrado
EQC2018-004897-P
EQUIPAMIENTO PARA PLATAFORMA DE FENOTIPADO MURINO
181K€
Cerrado
FLUBIODEM
Fluid Biomarkers for Neurodegenerative Dementias
2M€
Cerrado
PID2021-124430OA-I00
ESTUDIO DE LAS DIFERENCIAS DE SEXO EN ENFERMEDADES NEURODEGE...
157K€
Cerrado
Información proyecto PhenoTECH
Duración del proyecto: 24 meses
Fecha Inicio: 2020-09-17
Fecha Fin: 2022-09-30
Descripción del proyecto
The PhenoTECH project aims to develop a novel technology with high-throughput capacity for screening and phenotyping of genetic models of disease. PhenoTECH will enable an unprecedented capability to monitor and control multiple parameters that will significantly contribute to advancing fundamental and biopharmaceutical research, strongly accelerating discovery of novel treatments for debilitating neurodegenerative diseases. PhenoTECH’s immediate impact will be on the ERC Consolidator Grant, ALS-Networks, where we intend to utilize the power of zebrafish for high-throughput functional screens to uncover defective cellular pathways and to identify therapeutic targets for ALS and related neurodegenerative disorders. High-throughput phenotype-based screening efforts have until now been hampered by the lack of technology that would allow for parallel monitoring of behavioral, cellular and physiological markers of disease. To overcome this limitation, PhenoTECH will build an innovative platform for automated phenotypic analysis consisting of three modules: i) custom designed multiwell plates with the capacity for in-well perfusion of solutions, greatly facilitating and optimizing drug delivery, wash-out, temperature and oxygenation control; ii) state of the art motion (motor) tracking with analysis of spontaneous and evoked locomotion of zebrafish larvae; iii) fluorescence detection of genetically-encoded transgenic line reporters to enable live monitoring and imaging of cellular processes and neuronal activity. By combining these three capabilities, PhenoTECH will surpass any existing commercial product on the market and will enable low-cost, large-scale screening capability for development of efficient treatments to neurodegenerative diseases. PhenoTECH will have a strong societal and economic impact by providing a technological leap forward that will boost fundamental and biopharmaceutical research & development.